BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27598026)

  • 1. The role of Pap test screening against cervical cancer: a systematic review and meta-analysis.
    Meggiolaro A; Unim B; Semyonov L; Miccoli S; Maffongelli E; La Torre G
    Clin Ter; 2016; 167(4):124-39. PubMed ID: 27598026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis.
    Damiani G; Basso D; Acampora A; Bianchi CB; Silvestrini G; Frisicale EM; Sassi F; Ricciardi W
    Prev Med; 2015 Dec; 81():281-9. PubMed ID: 26408405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review.
    Saei Ghare Naz M; Kariman N; Ebadi A; Ozgoli G; Ghasemi V; Rashidi Fakari F
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):875-884. PubMed ID: 29693331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany.
    Petry KU; Barth C; Wasem J; Neumann A
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():132-139. PubMed ID: 28363186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Review of Barriers to Cervical Cancer Screening in Sub-Saharan Africa.
    McFarland DM; Gueldner SM; Mogobe KD
    J Nurs Scholarsh; 2016 Sep; 48(5):490-8. PubMed ID: 27434871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of two outreach strategies for cervical cancer screening.
    Bowles EJ; Gao H; Brandzel S; Bradford SC; Buist DS
    Prev Med; 2016 May; 86():19-27. PubMed ID: 26820221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
    Miller RA; Waters LL; Mody DR; Tams KC
    Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.
    Collins T; Stradtman LR; Vanderpool RC; Neace DR; Cooper KD
    Am J Prev Med; 2015 Aug; 49(2):324-30. PubMed ID: 26190807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
    Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
    J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
    Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
    BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.
    Salo H; Nieminen P; Kilpi T; Auranen K; Leino T; Vänskä S; Tiihonen P; Lehtinen M; Anttila A
    Int J Cancer; 2014 Jul; 135(1):204-13. PubMed ID: 24347441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cervical and breast cancer screening among immigrant women resident in Italy].
    Francovich L; Di Napoli A; Giorgi Rossi P; Gargiulo L; Giordani B; Petrelli A
    Epidemiol Prev; 2017; 41(3-4 (Suppl 1)):18-25. PubMed ID: 28929723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
    Watson M; Benard V; King J; Crawford A; Saraiya M
    Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening for survivors diagnosed with cancer before age 25.
    Tseng OL; Spinelli JJ; Dawes M; McBride ML
    J Cancer Surviv; 2017 Jun; 11(3):410-419. PubMed ID: 28127670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.